Last reviewed · How we verify

NCT03782714

Low-level Laser Therapy Versus Formocresol in Primary Molar Pulpotomies

Completed NA Last updated 20 December 2018
What this trial tests

NA trial testing Low-level laser therapy in Pulpotomy in 36 participants. Completed in 1 February 2018.

Timeline
1 February 2017
Primary endpoint
1 February 2018
1 February 2018

Quick facts

Lead sponsorKing Abdulaziz University
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingnone
Primary purposetreatment
Enrollment36
Start date1 February 2017
Primary completion1 February 2018
Estimated completion1 February 2018
Sites1 location across Saudi Arabia

Drugs / interventions tested

Conditions studied

Sponsor

King Abdulaziz University

Who can join

Adults 5 to 8, any sex, with Pulpotomy. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study aimed to assess and compare the clinical and radiographic success rates of LLLT and FC for pulpotomy in human primary teeth. One hundred and six primary molars from 36 children aging five to eight years were included and randomly assigned into two equal groups; LLLT group and FC group. Teeth were evaluated clinically and radiographically at 3, 6 and 12 months.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of Low-level laser therapy

Trials testing the same drug.

Other recruiting trials for Pulpotomy

Currently open trials in the same condition.

Other King Abdulaziz University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03782714.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing